Stay updated on Pembrolizumab for Genomic Instability Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This appears to be a minor front-end update with no visible changes to the study details or related content.
    Difference
    0.1%
    Check dated 2026-03-20T07:17:06.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:20:12.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    44 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. Core study details, eligibility criteria, and contact information appear unchanged.
    Difference
    0.1%
    Check dated 2026-02-12T01:54:34.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A minor revision update from v3.4.0 to v3.4.1 is shown; no other content changes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:39:21.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now includes a Show glossary option and new QC metadata labels, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the prior Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T21:18:26.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4. No study data, eligibility criteria, or locations were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:48:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.